Development and validation of blood tumor mutational burden reference standards

Eun-Ang Raiber-Moreau1, Guillem Portella2, Matthew G Butler3

  • 1Precision Medicine and Biosamples, Diagnostic Development Unit, AstraZeneca, Cambridge, UK.

Summary

We developed reference materials to standardize tumor mutational burden (TMB) testing in blood. These standards help ensure accurate and reproducible TMB measurements for immunotherapy selection across different labs and platforms.

Related Concept Videos